Written question asked by Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party) on Thursday, 24 June 2021, in the House of Lords. It was due for an answer on Thursday, 8 July 2021. It was answered by Lord Bethell (Conservative) on Tuesday, 6 July 2021 on behalf of the Department of Health and Social Care.
Coronavirus: Drugs
- Question
-
To ask Her Majesty's Government whether Ivermectin is being considered to treat mild cases of COVID-19.
- Answer
-
On 23 June, the PRINCIPLE clinical trial platform in the United Kingdom announced that ivermectin would be investigated to generate robust data on its effectiveness in treating adults aged 18 years old and over with mild COVID-19 who are at higher risk of developing serious illness. We will closely monitor the data from this trial, as well as emerging clinical trials worldwide to expand our evidence-base on the efficacy of ivermectin in treating COVID-19.
Secondary information
- Type
- Written question
- Reference
- HL1398
- Session
- 2021-22
- Subjects
- Drugs Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-10-30 13:14:00 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2021-22/HL1398
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2021-22/HL1398
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2021-22/HL1398